Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease



Status:Completed
Conditions:Parkinsons Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:35 - 75
Updated:11/2/2017
Start Date:December 2013
End Date:June 2015

Use our guide to learn which trials are right for you!

A Phase 2B, Twelve-week Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study, To Determine the Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease

This study will evaluate an oral fixed-dose, once daily product that combines pramipexole and
rasagiline for the treatment of early Parkinson's disease.

Animal studies support the therapeutic advantage of combining low doses of rasagiline and
pramipexole and suggest further improvement when both are administered in a sustained
fashion. Both rasagiline and pramipexole are well known marketed drugs for Parkinson's
disease with a good safety profile. combining the drugs in low doses and controlled release
may provide better symptom management than the existing drugs alone or together.


Inclusion Criteria:

- Subject is male or female ≥35 years of age to ≤75 years of age at the time of
enrollment.

- Subject has idiopathic Parkinson's disease consistent with the UK Brain Bank Criteria;
must have bradykinesia with sequence effect and rest tremor or prominent motor
asymmetry.

- Subject with disease duration no longer than 3 years and 0 months.

- Subject has a Hoehn & Yahr (H&Y) stage score of < 3.

- Subject has a MMSE score ≥ 26

Exclusion Criteria:

- Subject has an atypical parkinsonian syndrome or secondary parkinsonism (e.g., due to
drugs, metabolic neurogenetic disorders, encephalitis, cerebrovascular disease or
degenerative disease).

- Subject has a history of psychosis or hallucinations within the previous 12 months.

- Subject who is taking anticholinergic drugs.

- Subject has previous exposure to levodopa or a dopamine agonist for longer than 4
weeks; if previous exposure was less than 4 weeks then it must not be within 2 months
prior to the baseline visit.

- Subject has previous exposure to a MAO-B inhibitor for longer than 4 weeks; if
previous exposure was less than 4 weeks then it must not be within 3 months prior to
the baseline visit.

- Subject who is taking MAO inhibitors, potent CYP1A2 inhibitors, e,g, Ciprofloxacin,
Dextromethorphan or antitussive agent, analgesic agents such as tramadol, meperidine,
methadone and propoxyphene, strong 3A4 inducers, e.g., St. John's Wort or
cyclobenzaprine (tricyclic muscle relaxant), dopamine antagonists, such as the
neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide.
Probenecid, cimetidine, ranitidine, diltiazem, verapamil and quinidine.
We found this trial at
25
sites
Aurora, Colorado
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Augusta, Georgia
?
mi
from
Augusta, GA
Click here to add this to my saved trials
?
mi
from
Beer Yakov,
Click here to add this to my saved trials
Birmingham, Alabama
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Boca Raton, Florida
?
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Boston, Massachusetts
?
mi
from
Boston, MA
Click here to add this to my saved trials
Camden, New Jersey
?
mi
from
Camden, NJ
Click here to add this to my saved trials
Chicago, Illinois 60612
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Cincinnati, Ohio
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Commack, New York
?
mi
from
Commack, NY
Click here to add this to my saved trials
Durham, North Carolina
?
mi
from
Durham, NC
Click here to add this to my saved trials
Golden valley, Minnesota
?
mi
from
Golden valley, MN
Click here to add this to my saved trials
Houston, Texas
?
mi
from
Houston, TX
Click here to add this to my saved trials
Kansas City, Kansas
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
Los Angeles, California
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Manchester, Connecticut
?
mi
from
Manchester, CT
Click here to add this to my saved trials
New Brunswick, New Jersey
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
New Haven, Connecticut
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New York, New York
?
mi
from
New York, NY
Click here to add this to my saved trials
Port Charlotte, Florida
?
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Roanoke, Virginia
?
mi
from
Roanoke, VA
Click here to add this to my saved trials
Tampa, Florida
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Toledo, Ohio
?
mi
from
Toledo, OH
Click here to add this to my saved trials
Tulsa, Oklahoma
?
mi
from
Tulsa, OK
Click here to add this to my saved trials
West Bloomfield Township, Michigan
?
mi
from
West Bloomfield Township, MI
Click here to add this to my saved trials